| Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease L Rovedatti, T Kudo, P Biancheri, M Sarra, CH Knowles, DS Rampton, ... Gut 58 (12), 1629-1636, 2009 | 462 | 2009 |
| Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn’s disease strictures A Di Sabatino, CL Jackson, KM Pickard, M Buckley, L Rovedatti, ... Gut 58 (6), 777-789, 2009 | 227 | 2009 |
| Functional modulation of Crohn’s disease myofibroblasts by anti-tumor necrosis factor antibodies A Di Sabatino, SLF Pender, CL Jackson, JD Prothero, JN Gordon, ... Gastroenterology 133 (1), 137-149, 2007 | 209 | 2007 |
| Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease A Di Sabatino, KM Pickard, JN Gordon, V Salvati, G Mazzarella, ... Gastroenterology 133 (4), 1175-1187, 2007 | 147 | 2007 |
| Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease A Di Sabatino, L Rovedatti, R Kaur, JP Spencer, JT Brown, VD Morisset, ... The Journal of Immunology 183 (5), 3454-3462, 2009 | 127 | 2009 |
| Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease P Biancheri, RJ Brezski, A Di Sabatino, AR Greenplate, KL Soring, ... Gastroenterology 149 (6), 1564-1574. e3, 2015 | 121 | 2015 |
| Blockade of transforming growth factor β upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in … A Di Sabatino, KM Pickard, D Rampton, L Kruidenier, L Rovedatti, ... Gut 57 (5), 605-612, 2008 | 115 | 2008 |
| New pathogenic paradigms in inflammatory bowel disease A Di Sabatino, P Biancheri, L Rovedatti, TT MacDonald, GR Corazza Inflammatory bowel diseases 18 (2), 368-371, 2012 | 107 | 2012 |
| Absence of a role for interleukin‐13 in inflammatory bowel disease P Biancheri, A Di Sabatino, F Ammoscato, F Facciotti, F Caprioli, ... European journal of immunology 44 (2), 370-385, 2014 | 105 | 2014 |
| The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease A Di Sabatino, N Battista, P Biancheri, C Rapino, L Rovedatti, G Astarita, ... Mucosal immunology 4 (5), 574-583, 2011 | 103 | 2011 |
| Upper gastrointestinal bleeding in COVID-19 inpatients: Incidence and management in a multicenter experience from Northern Italy A Mauro, F De Grazia, MV Lenti, R Penagini, R Frego, S Ardizzone, ... Clinics and Research in Hepatology and Gastroenterology 45 (3), 101521, 2021 | 80 | 2021 |
| Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel … G Docena, L Rovedatti, L Kruidenier, A Fanning, NAB Leakey, ... Clinical & Experimental Immunology 162 (1), 108-115, 2010 | 69 | 2010 |
| Recent advances in understanding ulcerative colitis A Di Sabatino, P Biancheri, L Rovedatti, TT MacDonald, GR Corazza Internal and emergency medicine 7, 103-111, 2012 | 62 | 2012 |
| Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease A Di Sabatino, P Biancheri, S Piconese, MM Rosado, S Ardizzone, ... Inflammatory bowel diseases 16 (11), 1891-1897, 2010 | 58 | 2010 |
| Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut D Fina, E Franzè, L Rovedatti, GR Corazza, L Biancone, PP Sileri, G Sica, ... Mucosal Immunology 4 (2), 239-244, 2011 | 53 | 2011 |
| Fibroblast activation protein expression in Crohn's disease strictures L Rovedatti, A Di Sabatino, CH Knowles, N Sengupta, P Biancheri, ... Inflammatory bowel diseases 17 (5), 1251-1253, 2011 | 46 | 2011 |
| Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease P Biancheri, A Di Sabatino, L Rovedatti, P Giuffrida, SA Calarota, ... Inflammatory bowel diseases 19 (2), 259-264, 2013 | 43 | 2013 |
| Stromelysin-1 and macrophage metalloelastase expression in the intestinal mucosa of Crohn's disease patients treated with infliximab A Di Sabatino, U Saarialho-Kere, MG Buckley, JN Gordon, P Biancheri, ... European journal of gastroenterology & hepatology 21 (9), 1049-1055, 2009 | 34 | 2009 |
| Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin α4β7-positive … A Di Sabatino, L Rovedatti, MM Rosado, R Carsetti, GR Corazza, ... Human pathology 40 (5), 699-704, 2009 | 32 | 2009 |
| Recent advances in understanding Crohn’s disease A Di Sabatino, L Rovedatti, F Vidali, TT MacDonald, GR Corazza Internal and emergency medicine 8, 101-113, 2013 | 27 | 2013 |
